Tigan(r) (trimethobenzamide Hydrochloride) Injection
Product Images NDC 51662-1430

7 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tigan(r) (trimethobenzamide Hydrochloride) (NDC 51662-1430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of the active ingredient trimethobenzamide hydrochloride, showing its molecular framework including aromatic rings, substituents, and hydrochloride group.*
FDA Label Image

Vial Label (Vial Label)

Vial Label (Vial Label)
Label for TIGAN (trimethobenzamide hydrochloride) Injection with a strength of 100 mg/mL presented as 200 mg/2 mL. It is an intramuscular injection supplied in a 2 mL single-dose vial. The label includes usage restriction notes, distributor information for Par Pharmaceutical in Chestnut Ridge, NY, and placeholders for lot and expiration dates.*
FDA Label Image

Serialized Labeling (Serialized Labeling)

Serialized Labeling (Serialized Labeling)
Tigan (trimethobenzamide hydrochloride) Injection vial with a dosage strength of 200 mg/2 mL (100 mg/mL) for intramuscular use. The vial includes a label featuring the NDC number 42023-119-25. The packaging label includes a 2D barcode and distributor information for HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

Pouch (Pouch Label)

Pouch (Pouch Label)
TIGAN (TRIMETHOBENZAMIDE HYDROCHLORIDE) Injection 200 mg/2 mL (100 mg/mL) 2 mL vial label. The label includes NDC 51662-1430, lot number, expiration date, and instructions indicating intramuscular use only, preferably by deep IM injection. Manufactured by HF Acquisition Co LLC, Mukilteo, WA. The label directs to see the manufacturer’s package insert and storage instructions between 20° to 25°C.*
FDA Label Image

Vial Label (Vial Label X)

Vial Label (Vial Label X)
Label for TIGAN (trimethobenzamide hydrochloride) Injection, 200 mg/2 mL (100 mg/mL) intramuscular injection in a 2 mL single-dose vial. The label includes the NDC 42023-119-25, states Rx Only, and specifies it is not for use in children. Distributed by Par Pharmaceutical, Chestnut Ridge, NY.*
FDA Label Image

Case Labeling (Case Label)

Case Labeling (Case Label)
Label for TIGAN (TRIMETHOBENZAMIDE HYDROCHLORIDE) injection showing strength of 200 mg/2 mL (100 mg/mL) in a 2 mL vial, packaged as a case of 25. Indicated for intramuscular use, with manufacturer HF Acquisition Co LLC, DBA HealthFirst. Label includes lot and expiration information with storage instructions and dosing notes.*
FDA Label Image

Rfid Label (51662 1430 3 Rfid)

Rfid Label (51662 1430 3 Rfid)
Label on packaging for TIGAN(R) (Trimethobenzamide Hydrochloride) injection, 100 mg/mL, distributed by HF Acquisitions Co., LLC, Mukilteo, WA. The label includes a barcode, multiple sets of numeric codes, and directs to see the manufacturer's insert for more information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.